U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2Cr.3O.2H2O
Molecular Weight 188.021
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHROMIUM HYDROXIDE GREEN

SMILES

O.O.[O--].[O--].[O--].[Cr+3].[Cr+3]

InChI

InChIKey=CYYGBBNBGCVXEL-UHFFFAOYSA-N
InChI=1S/2Cr.2H2O.3O/h;;2*1H2;;;/q2*+3;;;3*-2

HIDE SMILES / InChI

Molecular Formula HO
Molecular Weight 17.0073
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Cr
Molecular Weight 51.9961
Charge 3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Chromium sulfate(III) hexahydrate or chromium sulphate, a trivalent compound of chromium that was investigated as a toxic compound. Experiments on rodent have shown chromium sulfate produced severe and widespread effects in the nasal cavity, larynx, lungs, and mediastinal lymph node. Effects were characterized by the accumulation of foreign material, infiltration of alveolar macrophages, septal cell hyperplasia, and granulomatous and chronic inflammation. Besides, chromium sulphate exerted a disadvantageous effect on the skeleton, as it decreases bone density and resistance.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
CHROMIUM

Approved Use

Chromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.

Launch Date

1.12000316E12
PubMed

PubMed

TitleDatePubMed
Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin.
1994 Jun
Silicate antibodies in women with silicone breast implants: development of an assay for detection of humoral immunity.
1996 Mar
Activation of MAPKs in human bronchial epithelial cells exposed to metals.
1998 Sep
Thirteen-week subchronic rat inhalation toxicity study with a recovery phase of trivalent chromium compounds, chromic oxide, and basic chromium sulfate.
1999 Dec
Status of antioxidant defense system in chromium-induced Swiss mice tissues.
2004 Jul
The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+.
2005 Dec 1
Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium.
2007 Aug
Effects of subchronic exposure via drinking water to a mixture of eight water-contaminating metals: a biochemical and histopathological study in male rats.
2007 Nov
The peripheral quantitative computed tomographic and densitometric analysis of skeletal tissue in male Wistar rats after chromium sulfate treatment.
2017 Sep 21
Patents

Patents

Substance Class Chemical
Created
by admin
on Fri Dec 15 16:34:55 UTC 2023
Edited
by admin
on Fri Dec 15 16:34:55 UTC 2023
Record UNII
RV8FT8XF5R
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHROMIUM HYDROXIDE GREEN
INCI  
INCI  
Official Name English
CHROME OXIDE (HYDRATED) GREEN
Common Name English
C.I. 77289
Common Name English
11958 GREEN
Common Name English
CI 77289
INCI  
INCI  
Official Name English
CI 77289 [INCI]
Common Name English
HYDRATED CHROMIUM SESQUIOXIDE
Common Name English
C.I. PIGMENT GREEN 18
Common Name English
CHROMIUM HYDROXIDE GREEN [INCI]
Common Name English
Code System Code Type Description
DAILYMED
RV8FT8XF5R
Created by admin on Fri Dec 15 16:34:55 UTC 2023 , Edited by admin on Fri Dec 15 16:34:55 UTC 2023
PRIMARY
PUBCHEM
22504267
Created by admin on Fri Dec 15 16:34:55 UTC 2023 , Edited by admin on Fri Dec 15 16:34:55 UTC 2023
PRIMARY
RXCUI
1312363
Created by admin on Fri Dec 15 16:34:55 UTC 2023 , Edited by admin on Fri Dec 15 16:34:55 UTC 2023
PRIMARY RxNorm
FDA UNII
RV8FT8XF5R
Created by admin on Fri Dec 15 16:34:55 UTC 2023 , Edited by admin on Fri Dec 15 16:34:55 UTC 2023
PRIMARY
CAS
12001-99-9
Created by admin on Fri Dec 15 16:34:55 UTC 2023 , Edited by admin on Fri Dec 15 16:34:55 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE